ID   4-11
AC   CVCL_2821
DR   ECACC; 11033103
DR   Wikidata; Q54602840
RX   Patent=US7537904;
CC   Group: Patented cell line.
CC   Population: African American.
CC   Characteristics: Stably expresses firefly luciferase under the control of the MMTV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ECACC=11033103
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
RX   Patent=US7537904;
RA   Ooe, Norihisa
RA   Matsunaga, Haruyuki
RT   "Cell for measuring the ability to control the activity of a
RT   ligand-responsive transcription control factor.";
RL   Patent number US7537904, 26-May-2009.
//